Serono closes Israeli plant
Switzerland's Serono, Europe's largest biotechnology company, has said it will close its InterPharm manufacturing plant in Ness Ziona, Israel, by the end of year.
Archives for September 21, 2004
New columns for LC-MS and 2D chromatography
Polymer Laboratories has launched a range of capillary and micro chromatography columns for small scale chromatography which use chemically stable polymeric particles to suit demanding high sensitivity separations in drug discovery applications...
Drugs from a wristwatch on the horizon
A drug delivery device worn like a wristwatch and programmed to administer doses automatically has been developed by Chrono Therapeutics and researchers at the University of Basel in Switzerland.
Gene therapy drug to transform dementia treatment?
The results of an ongoing study could revolutionise Alzheimer's disease treatment as a new technique, which uses a gene therapy agent to deliver a drug containing nerve growth factor (NGF), to the brain area affected by Alzheimer's disease, limiting...
Experimental drug blocks cancer-causing protein
An experimental drug that block signals promoting uncontrolled growth of blood cells, characteristic of Myeloproliferative Disease (MPD) reported improvement in a sufferer's symptoms raising the possibility of an effective cancer drug treatment where...
Boron Molecular expands in US
Australia's Boron Molecular has set up a US agent, Boron Molecular that aims to promote and increase the sale and distribution of the company's range of organoboron compounds throughout the US market.
Novagali raises €14m for drug delivery technology
French drug delivery specialist Novagali has raised €14 million in a second round of fundraising and says the cash will allow it to support its development programmes, based on a proprietary emulsion technology, for up to three years.
Lab-on-a-chip market driven by microfluidics
Constant innovation in the field of microfluidics and uTAS has enabled lab-on-a-chip (LOC) technologies to successfully enter the mainstream commercial market especially impacting on high-throughput screening of drug candidates, point of care testing...
SIRS-Lab releases new biochip
German biotechnological company SIRS-Lab, has introduced the Lab-Arraytor 60-inflammation, a biochip that comprises a total of 780 inflammation-defined genes, specifically to understand the molecular framework of acute inflammatory reactions.
Inyx buys inhaler technology
Inyx has acquired a Swiss-developed drug delivery technology that should make it possible to develop inhaled drug therapies with two or more active compounds, even if they are incompatible or unstable.